The Specimen Collection Cards Market Size is valued at 422.97 Mn in 2022 and is predicted to reach 660.55 Mn by the year 2031 at a 5.2 % CAGR during the forecast period for 2023-2031.
Small amounts of blood are spotted on filter paper, dried, and then analysed in a process known as dried blood spots (DBS). The procedure was developed to identify phenylketonuria, a hereditary metabolic disorder, in newborns. Recently evolving dried blood spot (DBS) collection cards are used to detect infectious diseases, particularly in resource-constrained areas, or to test infants for hereditary metabolic abnormalities. Growing research on DBS testing and its benefits for diagnostic reasons are anticipated to drive market expansion over the course of the projected period.
Additionally, because of the advantages of DBS in blood collection and transportation, the WHO recently suggested dried blood spot collection cards for diagnosing HIV and hepatitis B and C. The increased use of dried blood spot testing in resource-constrained environments, rising demand for newborn screening, increased use of dried blood spot testing for HIV surveillance, and rising prevalence of infectious diseases are key factors anticipated to propel market revenue growth over the forecast period. In addition, compared to liquid samples, increased laboratory automation, a decreased biohazard risk, and simpler storage are all expected to support market revenue growth in the future.
Competitive Landscape:
Some Major Key Players In The Specimen Collection Cards Market:
- QIAGEN
- PerkinElmer Inc.
- DBS System SA
- Danaher Corporation
- Eastern Business Forms, Inc.
- Ahlstrom
- ARCHIMED Life Science GmbH
- GenTegra LLC
- FortiusBio
- CENTOGENE N.V.
Market Segmentation:
The Specimen Collection Cards market is segmented on the basis of Type Of Specimen, Material, Product, Application, Distribution Channel, End-Use. By Type of Specimen is segmented into Blood, Saliva, Urine, Buccal Cells and Others. Whereas, By Material, the market is divided into Cotton & Cellulose-based, Fiber-based, and Others. The segmentation based on the Product Whatman 903, Ahlstrom 226, FTA, and Others.
The Application segment includes New Born Screening (NBS), Infectious Diseases Testing, Therapeutic Drug Monitoring, Forensics, Research, Wellbeing/Health Monitoring and Other Applications. By Distribution Channel the market is segmented into Online, Offline, the last segment End-Use Channel consists of Hospitals & Clinics, Diagnostics Centers, and Others.
Based On Product, The Whatman 903 Segment Is Accounted As A Major Contributor In The Specimen Collection Cards Market
In 2022, the Whatman 903 product category had a market share of 41.86%. Because more government-sponsored programmes and research projects are adopting it, the market is predicted to grow profitably in the near future. For instance, a study on evaluating the VIDAS HIV Duo Quick and Anti-HCV assays for dried blood specimen (DBS)-based serosurveillance was published in Scientific Reports in June 2022. The study claimed to have collected blood samples for HCV and HIV detection using Cytiva Whatman's 903 Protein Saver Card.
The Newborn Screening Segment Witnessed Growth At A Rapid Rate
The market for newborn screening is anticipated to expand quickly. Improvements in newborn screening, favourable governmental laws, and outstanding research & development for disease detection are largely responsible for the segment's rise. Additionally, it is anticipated that an increase in new product launches and debuts will hasten category expansion throughout the course of the projected year.
In The Region, The North American Specimen Collection Cards Market Holds A Significant Revenue Share
North America is likely to have a significant market share in the global market for dried blood spot collection cards due to the increased demand for newborn screening, the rising number of newborns, and the rising frequency of HIV infections. The expansion of the regional market as a whole is also attributed to technical advancements, a number of prominent rivals, rising healthcare spending, expanding R&D spending, and the presence of well-established healthcare infrastructure.
Specimen Collection Cards Market Report Scope:
|
Report Attribute |
Specifications |
|
Market Size Value In 2022 |
USD 422.97 Mn |
|
Revenue Forecast In 2031 |
USD 660.55 Mn |
|
Growth Rate CAGR |
CAGR of 5.2% from 2023 to 2031 |
|
Quantitative Units |
Representation of revenue in US$ Mn and CAGR from 2023 to 2031 |
|
Historic Year |
2019 to 2022 |
|
Forecast Year |
2023-2031 |
|
Report Coverage |
The forecast of revenue, the position of the company, the competitive market structure, growth prospects, and trends |
|
Segments Covered |
Type Of Specimen, Material, Product, Application, Distribution Channel, End-Use |
|
Regional Scope |
North America; Europe; Asia Pacific; Latin America; Middle East & Africa |
|
Country Scope |
U.S.; Canada; U.K.; Germany; China; India; Japan; Brazil; Mexico ;The UK; France; Italy; Spain; China; Japan; India; South Korea; South East Asia; South Korea; South East Asia |
|
Competitive Landscape |
QIAGEN; PerkinElmer Inc.; DBS System SA; Danaher Corporation; Eastern Business Forms, Inc.; Ahlstrom; ARCHIMED Life Science GmbH; GenTegra LLC; FortiusBio; CENTOGENE N.V. |
|
Customization Scope |
Free customization report with the procurement of the report, Modifications to the regional and segment scope. Particular Geographic competitive landscape. |
|
Pricing And Available Payment Methods |
Explore pricing alternatives that are customized to your particular study requirements. |
Corporate
Office :
Office No.5170, 5th Floor Marvel Fuego, Magarpatta Rd, Pune, 411028
info@insightaceanalytic.com
